摘要
胰腺癌由于其低切除率和化学耐药性,目前仍然是一个世界级问题和难以解决的负担。早期的诊断和治疗对克服胰腺癌是非常重要的。因此,急需新的诊断和预后生物标记物。在过去,研究人员主要集中于多种癌症的蛋白编码基因和表观遗传变异的研究,并且认为非编码部分没有用。然而近期,长非编码RNA在癌病变过程中是一个主要的作用物,因为它能调整细胞增殖、迁移、侵袭、转移、化疗抵抗等。在此基础上的机制主要集中在信号、诱导、引导、支架方面,但是特异性调整关系目前还未进行报道。几项研究已经揭示了一些长非编码RNA在胰腺癌细胞中参与生物功能时失调。本文我们将简短地概括下在胰腺癌中的功能性长非编码RNA,解释长非编码RNA可能的机制,进一步探索它们在胰腺癌中的重要性。
关键词: 长非编码RNA;胰腺癌;生物标记物;癌变;治疗;靶向
Current Molecular Medicine
Title:Long Non-Coding RNA: An Emerging Paradigm of Pancreatic Cancer
Volume: 16 Issue: 8
Author(s): T. Han, H. Hu, M. Zhuo, L. Wang, J.-J. Cui, F. Jiao, L.-W. Wang
Affiliation:
关键词: 长非编码RNA;胰腺癌;生物标记物;癌变;治疗;靶向
摘要: Pancreatic cancer remains a worldwide issue and burden that is hard to resolve given its low resection rate and chemo-resistance. Early diagnosis and early treatment are critical for conquering pancreatic cancer. Therefore, new biomarkers for diagnosis and prognosis are urgently needed. Previously, researchers mainly focused on protein-coding genetic and epigenetic changes in many types of cancers, and regarded the noncoding part as waste. Recently, however, long non-coding RNA (lncRNA) has emerged as a major participant in carcinogenesis, as it regulates cell proliferation, migration, invasion, metastasis, chemo-resistance, etc. The underlying mechanisms are summarized as signaling, decoy, guide and scaffold, yet the specific regulation networks remain to be uncovered. Several studies have revealed that some lncRNAs are dysregulated in pancreatic cancer, participating in biological functions. In this review, we will briefly outline the functional lncRNAs in pancreatic cancer, decipher possible mechanisms of lncRNAs, and further explore their significance in pancreatic cancer.
Export Options
About this article
Cite this article as:
T. Han, H. Hu, M. Zhuo, L. Wang, J.-J. Cui, F. Jiao, L.-W. Wang , Long Non-Coding RNA: An Emerging Paradigm of Pancreatic Cancer, Current Molecular Medicine 2016; 16 (8) . https://dx.doi.org/10.2174/1566524016666160927095812
DOI https://dx.doi.org/10.2174/1566524016666160927095812 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Role of Endocannabinoids in Pain Modulation and the Therapeutic Potential of Inhibiting their Enzymatic Degradation
Current Pharmaceutical Biotechnology Design, Synthesis and Evaluation of 8-Thiosubstituted 1,3,7- Trimethylxanthine Hydrazones with In-vitro Neuroprotective and MAO-B Inhibitory Activities
Medicinal Chemistry Mitochondrial Drug Targets in Cell Death and Cancer
Current Pharmaceutical Design Peripheral Benzodiazepine Receptor (PBR) New Insight in Cell Proliferation and Cell Differentiation Review
Current Clinical Pharmacology Caffeine; the Forgotten Potential for Parkinson's Disease
CNS & Neurological Disorders - Drug Targets Nanomedicine against Alzheimer’s and Parkinson’s Disease
Current Pharmaceutical Design Targeting Inhibitor of Apoptosis Proteins (IAPs) for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry The Ubiquitin+Proteasome Protein Degradation Pathway as a Therapeutic Strategy in the Treatment of Solid Tumor Malignancies
Anti-Cancer Agents in Medicinal Chemistry Bispecific Antibodies: An Innovative Arsenal to Hunt, Grab and Destroy Cancer Cells
Current Pharmaceutical Biotechnology MicroRNA and Multiple Myeloma: from Laboratory Findings to Translational Therapeutic Approaches
Current Pharmaceutical Biotechnology The Recent Development of α<sub>7</sub> Nicotinic Acetylcholine Receptor (nAChR) Ligands as Therapeutic Candidates for the Treatment of Central Nervous System (CNS) Diseases
Current Pharmaceutical Design Cellular Delivery In Vivo of siRNA-Based Therapeutics
Current Pharmaceutical Design Plausible Improvements for Selective Targeting of Dopamine Receptors in Therapy of Parkinson’s Disease
Mini-Reviews in Medicinal Chemistry Promotion of Apoptosis in Cancer Cells by Selective Purine-Derived Pharmacological CDK Inhibitors: One Outcome, Many Mechanisms
Current Pharmaceutical Design Structural and Molecular Basis of Carbohydrate-Protein Interaction Systems as Potential Therapeutic Targets
Current Pharmaceutical Design 1,2,3-Triazine Scaffold as a Potent Biologically Active Moiety: A Mini Review
Mini-Reviews in Medicinal Chemistry Targeting Ion Channels for New Strategies in Cancer Diagnosis and Therapy
Current Clinical Pharmacology Stem Cell-Like Brain Cancer Cells
Current Cancer Therapy Reviews Trafficking and Signaling of G Protein-Coupled Receptors in the Nervous System: Implications for Disease and Therapy
CNS & Neurological Disorders - Drug Targets Key miRNAs in Modulating Aging and Longevity: A Focus on Signaling Pathways and Cellular Targets
Current Molecular Pharmacology